324
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence

, , &
Pages 211-218 | Received 20 Aug 2015, Accepted 02 Dec 2015, Published online: 23 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (9)

Mahesh K. Shetty, Avice M. O’Connell, Daniel Kawakyu-O’Connor & Nidhi Sharma. 2021. Breast & Gynecological Diseases. Breast & Gynecological Diseases 1 26 .
Giacomo Pelizzari, Grazia Arpino, Laura Biganzoli, Saverio Cinieri, Michelino De Laurentiis, Lucia Del Mastro, Angelo Di Leo, Stefania Gori, Valentina Guarneri, Paolo Marchetti & Fabio Puglisi. (2018) An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project. BMC Cancer 18:1.
Crossref
Stefania Gori, Fabio Puglisi, Michela Cinquini, Giovanni Pappagallo, Antonio Frassoldati, Laura Biganzoli, Laura Cortesi, Alba Fiorentino, Catia Angiolini, Corrado Tinterri, Andrea De Censi, Alessia Levaggi & Lucia Del Mastro. (2018) Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM). European Journal of Cancer 99, pages 9-19.
Crossref
Emina Malisic, Snezana Susnjar, Jelena Milovanovic, Natasa Todorovic-Rakovic & Vesna Kesic. (2017) Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia. Archives of Gynecology and Obstetrics 297:2, pages 495-503.
Crossref
Gerald Davies, Liubov Lobanova, Wojciech Dawicki, Gary Groot, John R. Gordon, Matthew Bowen, Troy Harkness & Terra Arnason. (2017) Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer. PLOS ONE 12:12, pages e0187191.
Crossref
James E. Frampton. (2017) Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer. Drugs 77:18, pages 2037-2048.
Crossref
Wei Li, Xingpeng Shi, Yan Xu, Jianmei Wan, Shaohua Wei & Ran Zhu. (2017) Tamoxifen promotes apoptosis and inhibits invasion in estrogen-positive breast cancer MCF-7 cells. Molecular Medicine Reports 16:1, pages 478-484.
Crossref
Matteo Lambertini, Lucia Del Mastro, Giulia Viglietti, Noam F. Pondé, Cinzia Solinas & Evandro de Azambuja. (2017) Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer. Current Treatment Options in Oncology 18:1.
Crossref
Mariella Melo, Rodrigo De Vasconcelos‑Valen�a, Fidelis Neto, Rafael Borges, Danylo Costa‑Silva, Maria Barros‑Oliveira, Umbelina Borges, Airlane Alencar, Vladimir Silva & Benedito Da Silva. (2016) CYP2D6 gene polymorphisms in Brazilian patients with breast cancer treated with adjuvant tamoxifen and its association with disease recurrence. Biomedical Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.